- Home
- GIPR vs XXII Comparison
GIPR vs XXII Comparison
Compare GIPR & XXII Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | GIPR | XXII |
|---|---|---|
| Founded | 2015 | 1998 |
| Country | United States | United States |
| Employees | 4 | N/A |
| Industry | Real Estate Investment Trusts | Medicinal Chemicals and Botanical Products |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.9M | 3.3M |
| IPO Year | N/A | 2011 |
Fundamental Metrics
Financial Performance| Metric | GIPR | XXII |
|---|---|---|
| Price | $0.20 | $6.55 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 20.8M | 398.0K |
| Earning Date | 05-14-2026 | 05-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 69.96 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $25,832,530.00 |
| Revenue This Year | $1.88 | $370.28 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.16 | $0.27 |
| 52 Week High | $1.99 | $11.37 |
Technical Indicators
Market Signals| Indicator | GIPR | XXII |
|---|---|---|
| Relative Strength Index (RSI) | 39.37 | 91.43 |
| Support Level | $0.16 | $1.55 |
| Resistance Level | $0.28 | $6.86 |
| Average True Range (ATR) | 0.04 | 0.12 |
| MACD | -0.01 | 0.42 |
| Stochastic Oscillator | 10.37 | 87.94 |
Price Performance
Historical ComparisonAbout GIPR Generation Income Properties Inc.
Generation Income Properties Inc is an internally managed real estate investment trust focused on acquiring and managing income-producing retail, office, and industrial properties net leased to high-quality tenants in different states throughout the United States. Its key source of revenue is the rental income. The trust's properties are generally net leased to a single tenant.
About XXII 22nd Century Group Inc.
22nd Century Group Inc is a United States-based biotechnology company focused on utilizing alkaloid plant technologies to improve health and wellness with reduced nicotine tobacco, and hemp/cannabis. It has one operating segment; The tobacco segment is engaged in commercializing its proprietary VLNC tobacco plants and cigarette products, which contain nicotine than conventional tobacco and cigarettes, and research cigarettes sold under the brand name SPECTRUM. It derives a majority of its revenue from the tobacco segment.